Our Services
Medical Information
Helpful Resources
Published on: 12/4/2025
Does pregnancy affect hair loss? Yes. During pregnancy, higher estrogen and a Th2 immune shift often thicken hair and may improve alopecia areata (AA). After delivery, the hormone drop and immune rebound commonly trigger diffuse shedding 2–4 months postpartum—known as telogen effluvium—which usually resolves within 6–12 months. Postpartum changes can also cause AA flares, while female pattern hair loss is less affected but may be unmasked after birth.
Because your alopecia type, timing, and pregnancy- or breastfeeding-safe treatment options all shape next steps, understanding your specific situation matters. A free, instant, online symptom check can help you identify likely causes, gauge urgency, and prepare focused questions for your clinician—so you don't waste time guessing while shedding continues.
Reviewed for medical accuracy: 07/09/2026
Pregnancy brings profound hormonal and immune changes that can influence hair growth and shedding. For women with alopecia, understanding these effects can help set realistic expectations and guide supportive care. Below, we review how pregnancy and the postpartum period interact with different types of hair loss—particularly alopecia areata and postpartum telogen effluvium—and what you can do to manage symptoms.
"Pregnancy hair loss" often refers to the normal cycle of hair changes during and after pregnancy, but in women with alopecia it can have specific patterns:
Pregnancy induces a Th2-dominant immune profile to protect the fetus. Since alopecia areata is largely driven by Th1- and Th17-mediated inflammation around hair follicles:
According to a 2017 review in the Journal of the American Academy of Dermatology (Pratt et al.):
Key points for pregnant women with AA:
After delivery, up to 50–60% of women who improved during pregnancy may experience a flare of AA. Triggers include:
Strategies to reduce relapse severity:
Even without alopecia areata, many women notice hair shedding 2–4 months after delivery. This "baby blues" of the hair cycle is called telogen effluvium:
Tips for managing telogen effluvium:
Female pattern hair loss (FPHL) tends to be hormone-sensitive but is less dramatically affected by pregnancy:
If you suspect FPHL:
While many changes during and after pregnancy are normal, certain signs warrant prompt evaluation:
If you're experiencing any of these symptoms and want to understand whether they may be related to Alopecia Areata, Ubie's free AI-powered symptom checker can provide personalized insights in just 3 minutes to help guide your next steps.
Treatment during pregnancy and breastfeeding focuses on safety and symptom relief:
Topical Therapies
• Corticosteroid lotions or foams (low systemic absorption)
• Minoxidil 2% or 5% solution (discuss safety if breastfeeding)
Injectable Therapies
• Triamcinolone acetonide intralesional injections (widely used in AA)
• Platelet-rich plasma (PRP)—limited data but generally safe
Systemic Options (Postpartum Consideration)
• JAK inhibitors (e.g., tofacitinib, ruxolitinib)—promising for AA but not yet established in pregnancy.
• Systemic corticosteroids (short courses) for severe flares.
General Measures
• Balanced diet, hydration and sleep hygiene
• Gentle hair care—avoid tight styles, minimize chemical treatments
• Psychological support—consider counseling or support groups
Good nutrition supports both maternal health and hair growth:
Stress Management
• Mindful breathing, meditation apps
• Light exercise: walking, swimming, prenatal/postnatal yoga
• Adequate rest—nap when baby naps if possible
If you're experiencing significant hair loss during or after pregnancy, talk to your dermatologist or obstetrician. Early evaluation can help tailor treatments and provide reassurance.
Always consult your healthcare provider about any serious or life-threatening concerns, and before starting or stopping any treatment.
(References)
Pratt CH, King LE, Messenger AG, et al. (2017). Alopecia areata update: Part I. Epidemiology, clinical… J Am Acad Dermatol, 27793604.
D'Amico G, Garcia-Tsao G, Pagliaro L. (2006). Natural history and prognostic indicators of survival in cirrhosis:… J Hepatol, 16624889.
Friedrich-Rust M, Ong M-F, Herrmann E, et al. (2008). Performance of transient elastography for the staging of… Clin Gastroenterol Hepatol, 18276042.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.